Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 15, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment

LTBP1 is key regulator of TGF-β, a major driver of fibrosis. Latest target identified from company’s platform in collaboration with Dualsystems Biotech AG. SAN DIEGO, Dec. 15, 2022 (GLOBE...
December 02, 2022 06:18 ET | Source: Research and Markets

Global Home Decor Market Report to 2031 - Featuring Forbo International, Herman Miller, Kimball and Mannington Mills Among Others

Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "DIY Home Decor Market By Product Type, By Income Group, By Price Point, By Distribution Channel: Global Opportunity Analysis and Industry Forecast,...
November 16, 2022 02:12 ET | Source: Proficient Market Insights

Life Reinsurance Market Size In 2022 (New Report) | No. of pages: 115|: Manufacturers Data, Opportunity, Import Export Scenario, Application, Type, Regions and Future Forecast till 2028 with Top Growth Companies

Pune, Nov. 16, 2022 (GLOBE NEWSWIRE) -- "Life Reinsurance Market" research report focus on overall information that can help to take decisions on current market situation. Reinsurance, also known as...
November 10, 2022 16:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Third Quarter 2022 Results and Provides Corporate Update

First patient dosed in Phase 3 EFZO-FIT™ study in patients with pulmonary sarcoidosis; multiple centers in the U.S. are open for enrollment. Company to prioritize resources towards largest value...
November 10, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at Upcoming Investor Conferences

SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
November 09, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Publication of Positive Data from Phase 1b/2a Clinical Study of Efzofitimod for the Treatment of Pulmonary Sarcoidosis in the Journal CHEST

First therapy in sarcoidosis to reduce steroid burden while demonstrating improvements in key physiologic and quality of life measures. Global pivotal Phase 3 EFZO-FIT™ study currently enrolling. ...
November 03, 2022 09:00 ET | Source: ARCCAPTAIN

ARCCAPTAIN Releases the Best 200Amps MIG Welder MIG200 in 2022

NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- According to official news, the brand-new electric welding machine brand ARCCAPTAIN has released the new 200Amps mig welder MIG200, which is known as the...
October 28, 2022 05:43 ET | Source: Research and Markets

ASEAN Home Improvement Market Insights & Forecasts Report 2022: A $11.8 Billion Market in 2026 - Rising e-Commerce Penetration & Rising Trend of Freelancing

Dublin, Oct. 28, 2022 (GLOBE NEWSWIRE) -- The "ASEAN Home Improvement Market (Indonesia, Singapore, Philippines, Thailand & Malaysia): Insights & Forecast with Potential Impact of COVID-19...
October 25, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at the Jefferies London Healthcare Conference

SAN DIEGO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
October 20, 2022 07:08 ET | Source: Research and Markets

Insights on the Home Remodeling Global Market to 2030 - Featuring Andersen, Dow, Jeld-Wen Holdings and Kohler Among Others

Dublin, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The "Home Remodeling Market By Project Type, By Distribution Channel, By Application: Global Opportunity Analysis and Industry Forecast, 2020-2030" report...